|
Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma |
Doorduijn JK, Buijt I, van der Holt B, van Agthoven M, Sonneveld P, Uyl de Groot CA |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Doorduijn JK, Buijt I, van der Holt B, van Agthoven M, Sonneveld P, Uyl de Groot CA. Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. Haematologica 2004; 89(9): 1109-1117 Indexing Status Subject indexing assigned by NLM MeSH Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols /administration & Cost-Benefit Analysis; Cyclophosphamide /administration & Disease Progression; Disease-Free Survival; Doxorubicin /administration & Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor /administration & Health Care Costs; Health Resources /economics /utilization; Hospital Costs; Humans; Infection Control /economics; Lymphoma, Non-Hodgkin /drug therapy /economics; Male; Netherlands; Neutropenia /chemically induced /prevention & Prednisone /administration & Recombinant Proteins; Survival Analysis; Treatment Outcome; Vincristine /administration & control; dosage; dosage; dosage; dosage; dosage /adverse effects /therapeutic use; dosage /economics /therapeutic use AccessionNumber 22006006429 Date bibliographic record published 15/08/2006 |
|
|
|